Correlation Between Empresa Distribuidora and Mink Therapeutics
Can any of the company-specific risk be diversified away by investing in both Empresa Distribuidora and Mink Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Empresa Distribuidora and Mink Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Empresa Distribuidora y and Mink Therapeutics, you can compare the effects of market volatilities on Empresa Distribuidora and Mink Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Empresa Distribuidora with a short position of Mink Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Empresa Distribuidora and Mink Therapeutics.
Diversification Opportunities for Empresa Distribuidora and Mink Therapeutics
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Empresa and Mink is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Empresa Distribuidora y and Mink Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mink Therapeutics and Empresa Distribuidora is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Empresa Distribuidora y are associated (or correlated) with Mink Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mink Therapeutics has no effect on the direction of Empresa Distribuidora i.e., Empresa Distribuidora and Mink Therapeutics go up and down completely randomly.
Pair Corralation between Empresa Distribuidora and Mink Therapeutics
Considering the 90-day investment horizon Empresa Distribuidora y is expected to generate 1.14 times more return on investment than Mink Therapeutics. However, Empresa Distribuidora is 1.14 times more volatile than Mink Therapeutics. It trades about 0.53 of its potential returns per unit of risk. Mink Therapeutics is currently generating about 0.06 per unit of risk. If you would invest 2,910 in Empresa Distribuidora y on September 1, 2024 and sell it today you would earn a total of 1,088 from holding Empresa Distribuidora y or generate 37.39% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Empresa Distribuidora y vs. Mink Therapeutics
Performance |
| Timeline |
| Empresa Distribuidora |
| Mink Therapeutics |
Empresa Distribuidora and Mink Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Empresa Distribuidora and Mink Therapeutics
The main advantage of trading using opposite Empresa Distribuidora and Mink Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Empresa Distribuidora position performs unexpectedly, Mink Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will offset losses from the drop in Mink Therapeutics' long position.| Empresa Distribuidora vs. MGE Energy | Empresa Distribuidora vs. CMS Energy | Empresa Distribuidora vs. OGE Energy | Empresa Distribuidora vs. DTE Energy |
| Mink Therapeutics vs. Affimed NV | Mink Therapeutics vs. Adaptimmune Therapeutics Plc | Mink Therapeutics vs. Sangamo Therapeutics | Mink Therapeutics vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |